Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on June 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Infinium Global Diversity Array Kits.

Closed
75N98026Q00671Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
FDA Office Of Acq Grant Svcs

POSTED

about 17 hours ago

DEADLINE

in 5 days
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

1 day ago

DEADLINE

in 20 days
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

1 day ago

DEADLINE

in 20 days
NAICS: 541714
Federal
Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)
Solicitation # W911SR-26-9-CADENCC
The Department of the Army, through the Army Contracting Command Edgewood Contracting Division and the Joint Project Lead Enabling Technologies, is seeking preproposals for the Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability project. This initiative aims to accelerate clinical trial startups for CBRN defense readiness by implementing Master Protocols, utilizing innovative technologies for decentralized trial operations, and establishing a pre-positioned clinical trial site network. The project will primarily focus on Phase I and Phase II clinical trials for early treatment products, post-exposure prophylaxis, and pre-exposure prophylaxis, including those under the Animal Rule. This opportunity is issued under 10 USC 4022 Other Transaction Authority for a prototype project, with the potential for non-competitive follow-on production contracts for successful performers. Preproposals are due by 1500 hours on September 17, 2026, and must be limited to 10 pages. Evaluation will be based on technical merit, military relevance, technology readiness level 4 or above, regulatory compliance with FDA guidelines, and best overall value. Prospective awardees must be registered in the System for Award Management database.
W6QK Acc-Apg

POSTED

8 days ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The National Institutes of Health, through its Office of Logistics and Operations, is seeking to procure Infinium Global Diversity Array Kits from Illumina, Inc. under a non-competitive award authorized by FAR Part 13 Simplified Acquisition Procedures. The acquisition, identified by solicitation number 75N98026Q00671 and posted on June 22, 2026, with a response deadline of July 2, 2026, is justified solely on the basis of Illumina’s unique and irreplaceable technical capabilities. As the sole manufacturer of the Infinium arrays, Illumina provides proprietary technical support through its team of Technical Applications Scientists and Field Application Scientists, who are uniquely qualified to troubleshoot assay failures and supply replacement reagents free of charge when necessary—capabilities that no other vendor can match. This exclusive support is the definitive factor in the decision to award without competition, with no formal evaluation factors, scoring criteria, or trade-off analysis applied. The place of performance is Bethesda, Maryland, where the kits will be delivered and operated, and the contract value is expected to remain under the $350,000 simplified acquisition threshold. Response to this presolicitation requires electronic submission of a technical proposal, cost-price proposal, period of performance details, Unique Entity ID, Taxpayer Identification Number, and a business size certification to the designated point of contact at NIH. While no formal contract clauses, packaging standards, inspection criteria, or delivery terms such as FOB are specified, the procurement relies on Illumina’s established support infrastructure to ensure ongoing assay reliability and performance. The contracting office is located at 6701 Rockledge Drive, Bethesda, MD 20817, and all submissions must be sent via email to vishnuh@mail.nih.gov; fax submissions are prohibited. Although no additional attachments, invoicing methods, payment details, or accounting codes are provided, the requirement for business size certification aligns with the NAICS code 541714, which sets a $34 million annual receipts threshold for small business status. The contract is anticipated to be a firm-fixed-price award, but pricing details have not been disclosed at this presolicitation stage.

General Info

Illumina exclusively provides Infinium arrays with free troubleshooting and replacements; NIH seeks procurement by July 2, 2026.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

Presolicitation Notice 75N98026Q00671 for Infinium Global Diversity Array Kits

DOCXpresolicitation

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts
Vishnuvajjala Hanumanth Rao

Full Description

Show more

As the manufacturer of the Infinium Methylation Global Diversity Array, Illumina, Inc is uniquely situated to provide technical support for the arrays and reagents in the case of assay failure. The Illumina product support service team includes highly qualified technical applications scientists (TAS), and field application scientists (FAS) and others that are deeply familiar with the intricacies of the assay system and are able to troubleshoot and provide replacement reagents FOC if necessary. NO other provider is able to provide this level of support for the arrays

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS